Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.

David Lindgren; Fredrik Liedberg; Anna Andersson; G Chebil; Sigurdur Gudjonsson; Åke Borg; Wiking Månsson; Thoas Fioretos; Mattias Höglund

doi:10.1038/sj.onc.1209249

Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.

David Lindgren, Fredrik Liedberg, Anna Andersson, G Chebil, Sigurdur Gudjonsson, Åke Borg, Wiking Månsson, Thoas Fioretos, Mattias Höglund

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

Originalspråk	engelska
Sidor (från-till)	2685-2696
Tidskrift	Oncogene
Volym	25
Nummer	18
DOI	https://doi.org/10.1038/sj.onc.1209249
Status	Published - 2006

Ämnesklassifikation (UKÄ)

Cancer och onkologi

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1038/sj.onc.1209249

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16532037&dopt=Abstract

Citera det här

@article{45709c535d1744e8a73dbb35cb8ed920,

title = "Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.",

author = "David Lindgren and Fredrik Liedberg and Anna Andersson and G Chebil and Sigurdur Gudjonsson and {\AA}ke Borg and Wiking M{\aa}nsson and Thoas Fioretos and Mattias H{\"o}glund",

year = "2006",

doi = "10.1038/sj.onc.1209249",

language = "English",

volume = "25",

pages = "2685--2696",

journal = "Oncogene",

issn = "1476-5594",

publisher = "Nature Publishing Group",

number = "18",

}

TY - JOUR

T1 - Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.

AU - Lindgren, David

AU - Liedberg, Fredrik

AU - Andersson, Anna

AU - Chebil, G

AU - Gudjonsson, Sigurdur

AU - Borg, Åke

AU - Månsson, Wiking

AU - Fioretos, Thoas

AU - Höglund, Mattias

PY - 2006

Y1 - 2006

U2 - 10.1038/sj.onc.1209249

DO - 10.1038/sj.onc.1209249

M3 - Article

C2 - 16532037

SN - 1476-5594

VL - 25

SP - 2685

EP - 2696

JO - Oncogene

JF - Oncogene

IS - 18

ER -